Search -

Displaying 161 - 180 of 1408

Sort: Relevancy | Date

News Conference News SCAI 2024

PCI and TAVI Safe, Even When Done at the Same Time: TVT Registry

L.A. McKeown

May 07, 2024

News Daily News

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

Michael O'Riordan

May 06, 2024

News Daily News

As US Rollout Begins for Coronary DCBs, Interventionalists Mull Practice Changes

Todd Neale

May 03, 2024

News Conference News SCAI 2024

AI Picks Up on Info Operators Miss on Angiograms: AI-ENCODE

L.A. McKeown

May 03, 2024

News Daily News

Again and Again, Trials Back Short DAPT Post-PCI in ACS: Practice Slow to Shift

Yael L. Maxwell

May 03, 2024

News Conference News SCAI 2024

CALORI: More Support for Eschewing Fasting Protocols Preprocedure

L.A. McKeown

May 02, 2024

News Features

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Caitlin E. Cox

May 02, 2024

News Opinion CV Team Dispatch

May 2024 Dispatch for the CV Team

L.A. McKeown

May 01, 2024

News Daily News

INOCA May Be at the Root of Angina for Many Long-COVID Patients

Caitlin E. Cox

April 17, 2024

Presentation Fellows 2024

Wire/Balloon/Catheter/Stent Technology: Fundamentals of Design and Use

Presenter: Margaret B. McEntegart

April 12, 2024

Presentation Fellows 2024

Coronary Angiography: Indications, Limitations, and Artifacts

Presenter: Chad Rammohan

April 12, 2024

News Conference News ACC 2024

PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE

L.A. McKeown

April 08, 2024

$Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC$

News Conference News ACC 2024

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Michael O'Riordan

April 08, 2024

$Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)$

Presentation ACC 2024

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

Presenter: Rasha K. Al-Lamee

April 08, 2024

Presentation ACC 2024

PREVENT: Preventive PCI versus Medical Therapy Alone for Treatment of Vulnerable Atherosclerotic Coronary Plaques

Presenter: Seung-Jung Park

April 07, 2024

News Conference News ACC 2024

Early Empagliflozin Doesn’t Curb HF Hospitalizations, Deaths Post-MI: EMPACT-MI

Shelley Wood

April 06, 2024

News Opinion CV Team Dispatch

April 2024 Dispatch for the CV Team

L.A. McKeown

April 01, 2024

News Conference News ACC 2024

Even When Nearby, Public AEDs Get Little Use in OHCA

L.A. McKeown

March 28, 2024

News Daily News

Abiomed Recalls Labeling for Left-Sided Impella Pumps: FDA

Caitlin E. Cox

March 21, 2024

News Conference News CRT 2024

Comprehensive Radiation Shield Sharply Cuts Operator Exposure

L.A. McKeown

March 19, 2024

Advertisement

PCI and TAVI Safe, Even When Done at the Same Time: TVT Registry

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

As US Rollout Begins for Coronary DCBs, Interventionalists Mull Practice Changes

AI Picks Up on Info Operators Miss on Angiograms: AI-ENCODE

Again and Again, Trials Back Short DAPT Post-PCI in ACS: Practice Slow to Shift

CALORI: More Support for Eschewing Fasting Protocols Preprocedure

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

May 2024 Dispatch for the CV Team

INOCA May Be at the Root of Angina for Many Long-COVID Patients

Wire/Balloon/Catheter/Stent Technology: Fundamentals of Design and Use

Coronary Angiography: Indications, Limitations, and Artifacts

PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE

Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC

Coronary Sinus Reducer for the treatment of refractory angina: a randomised, placebo-controlled trial (ORBITA-COSMIC)

PREVENT: Preventive PCI versus Medical Therapy Alone for Treatment of Vulnerable Atherosclerotic Coronary Plaques

Early Empagliflozin Doesn’t Curb HF Hospitalizations, Deaths Post-MI: EMPACT-MI

April 2024 Dispatch for the CV Team

Even When Nearby, Public AEDs Get Little Use in OHCA

Abiomed Recalls Labeling for Left-Sided Impella Pumps: FDA

Comprehensive Radiation Shield Sharply Cuts Operator Exposure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content